1. A Human Recombinant Autoantibody-Based Immunotoxin Specific for the Fetal Acetylcholine Receptor Inhibits Rhabdomyosarcoma Growth In Vitro and in a Murine Transplantation Model. (24th February 2010) Authors: Gattenlöhner, S.; Jörißen, H.; Huhn, M.; Vincent, A.; Beeson, D.; Tzartos, S.; Mamalaki, A.; Etschmann, B.; Muller-Hermelink, H. K.; Koscielniak, E.; Barth, S.; Marx, A. Other Names: Anand Rene Academic Editor. Journal: Journal of biomedicine and biotechnology Issue: Volume 2010(2010) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Heterogeneity and immunotherapy of specific T-cells in myasthenia gravis. (May 1997) Authors: Bond, A.; Corlett, L.; Nagvekar, N.; Jacobson, L.; Pantic, N.; Beeson, D.; Nicolle, M.; Vincent, A.; Newsom-Davis, J.; Spack, E.; Willcox, N. Journal: Biochemical Society transactions Issue: Volume 25:Number 2(1997) Page Start: 665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Paediatric autoimmune myasthenia gravis: Any prognostic factor for disease remission?. (June 2017) Authors: Vecchio, D.; Rodríguez Cruz, P.; Hilton-Jones, D.; Beeson, D.; Jayawant, S.; Ramdas, S.; Pitt, M.; DeVile, C.; Robb, S.; Munot, P.; Palace, J. Journal: European journal of paediatric neurology Issue: Volume 21(2017)Supplement 1 Page Start: e233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗